Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis

被引:75
作者
Correale, Jorge [1 ]
Villa, Andres [2 ]
机构
[1] FLENI, Raul Carrea Inst Neurolog Res, Dept Neurol, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Neurol, Jose Maria Ramos Hosp, Buenos Aires, DF, Argentina
关键词
multiple sclerosis; CD8+T cells; CD94/NKG2A; IL-15; CD28-;
D O I
10.1016/j.jneuroim.2007.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate CD8+ regulatory T cell influence on multiple sclerosis development, peripheral blood and cerebrospinal fluid (CSF) CD8+ T cell clones (TCCs) recognizing MBP83-102 and MOG(63-87)-specific CD4+ T cells were isolated from 20 patients during acute exacerbations, 15 in remission and 15 controls. Blood and CSF CD8+ regulatory TCC cloning frequency decreased more during exacerbations than remissions or controls. Target cell pre-activation significantly enhanced CD8+ T granule-mediated cell killing of CD4+ targets, and was restricted by HLA-E. During exacerbations, killer-inhibitory receptor CD94/NKG2A expression was significantly higher in CD8+ TCCs, limiting their cytotoxic activity. Moreover, IL-15 and IFN-gamma significantly increased CD94 and NKG2A expression. These data provide evidence that CD94/NKG2A receptors play an important role in regulating T cell activity during the course of MS. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:121 / 134
页数:14
相关论文
共 66 条
[1]   IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN [J].
ALDRICH, CJ ;
DECLOUX, A ;
WOODS, AS ;
COTTER, RJ ;
SOLOSKI, MJ ;
FORMAN, J .
CELL, 1994, 79 (04) :649-658
[2]  
ANTEL J, 1986, J IMMUNOL, V137, P3436
[3]  
ANTEL JP, 1986, J IMMUNOL, V137, P136
[4]   Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission [J].
Araki, M ;
Kondo, T ;
Gumperz, JE ;
Brenner, MB ;
Miyake, S ;
Yamamura, T .
INTERNATIONAL IMMUNOLOGY, 2003, 15 (02) :279-288
[5]   Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis [J].
Astier, Anne L. ;
Meiffren, Gregory ;
Freeman, Samuel ;
Hafler, David A. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (12) :3252-3257
[6]   Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction [J].
Babbe, H ;
Roers, A ;
Waisman, A ;
Lassmann, H ;
Goebels, N ;
Hohlfeld, R ;
Friese, M ;
Schröder, R ;
Deckert, M ;
Schmidt, S ;
Ravid, R ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :393-404
[7]   SUPPRESSOR AND CYTOLYTIC CELL-FUNCTION IN MULTIPLE-SCLEROSIS - EFFECTS OF CYCLOSPORINE-A AND INTERLEUKIN-2 [J].
BANIA, MB ;
ANTEL, JP ;
REDER, AT ;
NICHOLAS, MK ;
ARNASON, BGW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :582-586
[8]  
Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO
[9]  
2-Y
[10]   Cathepsin D triggers bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis [J].
Bidère, N ;
Lorenzo, HK ;
Carmona, S ;
Laforge, M ;
Harper, F ;
Dumont, C ;
Senik, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :31401-31411